Biotechnology | FDA | Influenza | Vaccine
FDA approved quadrivalent formulation of Fluarix
On Dec. 14, 2012, the U.S. Food and Drug Administration (FDA) announced it had approved GlaxoSmithKline’s quadrivalent formulation…
-
-
Amgen acquired deCODE Genetics for $415 million
On Dec. 12, 2012, deCODE genetics announced an agreement whereby Amgen acquired deCODE Genetics, a global leader in…
-
Agriculture | Biotechnology | Genomics | USDA
USDA scientists and cooperators sequenced wheat genome
On Nov. 28, 2012, scientists from the USDA’s Agricultural Research Service (ARS), as part of an international team,…
-
Biotechnology | FDA | Influenza | Vaccine
FDA approved first seasonal influenza vaccine manufactured using cell culture technology
On Nov. 20, 2012, the U.S. Food and Drug Administration (FDA) announced it had approved first seasonal influenza…
-
A milestone in protection from influenza was reached with FDA approval for Novartis to manufacture seasonal influenza vaccine using cell-based technology in a US facility
On Nov. 20, 2012, the FDA approved a seasonal flu vaccine produced by Novartis using animal cell culture…
-
The CDC responded to the large fungal meningitis outbreak
On Nov. 15, 2012, the U.S. Centers for Disease Control and Prevention (CDC) responded to the fungal meningitis…
-
International team sequenced the bread wheat genome
On Nov. 14, 2012, scientists from the U.S., United Kingdom and Germany announced they had completed the first…
-
Atossa Genetics completed its IPO
On Nov. 8, 2012, Atossa Genetics, the Breast Health Company completed its IPO with gross proceeds of $4…
-
ACIP voted to recommend use of HibMenCY vaccine in infants at increased risk for meningococcal disease
On Oct. 24, 2012, the Immunization Practices Advisory Committee (ACIP) voted to recommend use of HibMenCY (Menhibrix, GlaxoSmithKline),…
-
ACIP voted to recommend that pregnant women receive a dose of Tdap during each pregnancy
On Oct. 24, 2012, the Immunization Practices Advisory Committee (ACIP) voted 14-0 with one abstention to recommend that…
-
LigoCyte Pharmaceuticals was acquired Takeda Pharmaceutical
On Oct. 3, 2012, Takeda Pharmaceutical acquired LigoCyte for an upfront payment of $60 million, with future contingent…
-
The Connecticut Challenge Survivorship Clinic Opened at Yale Cancer Center
On Sept. 28, 2012, the Connecticut Challenge Survivorship Clinic opened at Yale Cancer Center providing — the first…
-
Oregon Health & Science University Received $125 Million Gift From Nike Founder
On Sept. 19, 2012, Oregon Health & Science University (OHSU) in Portland announced that it had received a…
-
Grateful family left more than $10 million to support OHSU
On Sept. 10, 2012, Oregon Health Science University (OHSU) announced the estate of Garthe and Grace Brown designated…
-
2012 Lasker awards honor scientists for groundbreaking medical research
On Sept. 10, 2012, the Albert and Mary Lasker Foundation announced winners of the annual Lasker Awards: Michael…
-
A new phlebovirus (Heartland virus) associated with severe febrile illness in Missouri published
On Aug. 30, 2012, a new phlebovirus, discovered in northwestern Missouri by Dr. Scott Folk of Heartland Regional…
-
Lucentis approved for treatment of diabetic macular edema
On Aug. 10. 2012, Genentech announced that Lucentis (ranibizumab injection) was approved by the U.S. Food and Drug…
-
Human Genome Sciences was acquired by GlaxoSmithKline for $3.6 billion
On Aug. 3, 2012, GlaxoSmithKline announced that it had completed its acquisition of Human Genome Sciences for $3.6…
-
The Connecticut Development Authority was merged into Connecticut Innovations
On Jul. 31, 2012, the Connecticut Development Authority (CDA) was merged into Connecticut Innovations (CI) which was created…
-
The CDC responded to a multi-state outbreak of salmonella infections associated with raw tuna
On Jul. 26, 2012, the U.S. Centers for Disease Control and Prevention (CDC) responded to a multi-state outbreak…
-
Meta Analysis Study Shows Impact of fluoride on neurological development in children
On Jul. 25, 2012, in a meta-analysis, researchers from the China Medical University in Shenyang and Harvard School…
-
The University of Kansas Cancer Center earned National Cancer Institute designation
On Jul. 12, 2012, a decade after declaring its goal of becoming a National Cancer Institute-designated facility, the…
-
The FDA’s “Breakthrough Therapy Designation” was created
On Jul. 9, 2012, the FDA created the “Breakthrough Therapy Designation” that expedites development and review of drugs…
-
The NIH awarded $65 million grant to Institute for Translational Health Sciences to turn promising discoveries into patient care advances
On Jul. 9, 2012, the National Institutes of Health (NIH) announced it had awarded a $65 million five…
-
Biotechnology | Diagnostics | NIH | Oncology | Radiology | Therapeutics
The University of Hawaii Cancer Center received NCI designation renewal
On Jun. 29, 2012, following a competitive renewal process, the National Cancer Institute announced it had awarded the…
-
Roche announced the closure of the Nutley/Clifton campus
On Jun. 26, 2012, Roche announced it had closed the Nutley plant, established in 1929. The Nutley plant…
-
The Helix Center Biotech Incubator opened its doors
On Jun. 25, 2012, The St. Louis County Economic Council is opening the doors to its new biotech…
-
Rocky Mountain Biological Laboratory announced $10 million legacy campaign
On Jun. 25, 2012, the Rocky Mountain Biological Laboratory (RMBL) announced the unveiling of its Legacy Campaign, a…
-
Biotechnology | Disease | FDA | Vaccine
FDA approved HibMenCY vaccine for infants
On Jun. 24, 2012, the U.S. Food and Drug Administration (FDA) announced it had approved HibMenCY (Menhibrix, GlaxoSmithKline),…
-
Oxford University researchers dated relics as first century AD
On Jun. 15, 2012, Oxford University researchers announced research from excavations in 2010 on the Black Sea island…
